Decline of Nonrecommended HIV Care in Medicare
|
A recent study shows a substantial decline in the use of
nonrecommended antiviral prescriptions among Medicare beneficiaries with HIV. |
FDA slaps clinical hold on multiple Gilead HIV trials
Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...